초록 ▼

Compositions are provided that contain a TRPV1 agonist, such as capsaicin, and a solvent system. Topical application of the composition results in rapid delivery of agonist to the dermis and epidermis. Method of using the compositions for reducing nociceptive nerve fiber function in subjects, and fo

Compositions are provided that contain a TRPV1 agonist, such as capsaicin, and a solvent system. Topical application of the composition results in rapid delivery of agonist to the dermis and epidermis. Method of using the compositions for reducing nociceptive nerve fiber function in subjects, and for treatment of capsaicin-responsive conditions are also provided.

대표청구항 ▼

1. A liquid formulation comprising: about 20% (w/v) capsaicin;a solvent system, the solvent system comprising about 60% (v/v) to about 90% (v/v) propylene glycol and about 10% (v/v) to about 30% (v/v) oleyl alcohol; andless than 1% (w/v) of a stabilizer. 2. The liquid formulation of claim 1, further

1. A liquid formulation comprising: about 20% (w/v) capsaicin;a solvent system, the solvent system comprising about 60% (v/v) to about 90% (v/v) propylene glycol and about 10% (v/v) to about 30% (v/v) oleyl alcohol; andless than 1% (w/v) of a stabilizer. 2. The liquid formulation of claim 1, further comprising a local anesthetic. 3. The liquid formulation of claim 1, wherein the liquid formulation is contained in a microemulsion. 4. The liquid formulation of claim 1, wherein the stabilizer is selected from the group consisting of antioxidants, chelators, preservatives, disodium edetate, beta-carotene, tocopherols, beta-tocopherols, tocopherol acetate, octyl gallate, ascorbyl palmitate, butylated hydroxyanisole, butylated hydroxytoluene, antimicrobial agents, parabens, methylparaben, propylparaben, butylparaben, methyl salicylate, phenethyl alcohol, and resorcinol. 5. The liquid formulation of claim 4, wherein the stabilizer is butylated hydroxytoluene. 6. The liquid formulation of claim 1, wherein the solvent system comprises about 60% (v/v) propylene glycol. 7. The liquid formulation of claim 1, wherein the solvent system comprises about 70% (v/v) propylene glycol. 8. The liquid formulation of claim 1, wherein the solvent system comprises about 75% (v/v) propylene glycol. 9. The liquid formulation of claim 1, wherein the solvent system comprises about 80% (v/v) propylene glycol. 10. The liquid formulation of claim 1, wherein the solvent system comprises about 90% (v/v) propylene glycol. 11. The liquid formulation of claim 1, wherein the solvent system comprises about 10% (v/v) oleyl alcohol. 12. The liquid formulation of claim 1, wherein the solvent system comprises about 25% (v/v) oleyl alcohol. 13. The liquid formulation of claim 1, wherein the solvent system comprises about 30% (v/v) oleyl alcohol. 14. The liquid formulation of claim 1, further comprising less than 1% of a colorant. 15. The liquid formulation of claim 6, wherein the stabilizer is butylated hydroxytoluene. 16. The liquid formulation of claim 7, wherein the stabilizer is butylated hydroxytoluene. 17. A liquid formulation comprising: about 20% (w/v) capsaicin;a solvent system, the solvent system comprising about 70% (v/v) propylene glycol and the remainder oleyl alcohol; andless than about 1% (w/v) of a stabilizer. 18. The liquid formulation of claim 17, wherein the stabilizer is butylated hydroxytoluene. 19. A liquid formulation comprising: about 20% (w/v) capsaicin;a solvent system, the solvent system comprising about 60% (v/v) propylene glycol and the remainder oleyl alcohol; andless than about 1% (w/v) of a stabilizer. 20. The liquid formulation of claim 19, wherein the stabilizer is butylated hydroxytoluene.